<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>14(3)</volume><submitter>Cremoni M</submitter><pubmed_abstract>Kidney transplant (KT) recipients are at increased risk of developing severe forms of COVID-19. Little is known about the immunological mechanisms underlying disease severity in these patients receiving T-cell targeting immunosuppressive drugs. We investigated the relationship between T cell responsiveness at the beginning of the infection and the risk of subsequent progression to respiratory failure. We performed a multicentric prospective study in KT recipients with a positive RT-PCR COVID-19 test and only mild symptoms at inclusion. Blood samples were collected at baseline in a cell culture system containing T cell stimuli. We assessed T cell responsiveness by computing the ratio between the levels of Th1, Th2, Th17 and Treg cytokines produced after polyclonal stimulation and the number</pubmed_abstract><journal>Viruses</journal><pagination>542</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC8949290</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Low T Cell Responsiveness in the Early Phase of COVID-19 Associates with Progression to Severe Pneumonia in Kidney Transplant Recipients.</pubmed_title><pmcid>PMC8949290</pmcid><pubmed_authors>Demonchy E</pubmed_authors><pubmed_authors>Caillard S</pubmed_authors><pubmed_authors>Esnault V</pubmed_authors><pubmed_authors>Massa F</pubmed_authors><pubmed_authors>Glaichenhaus N</pubmed_authors><pubmed_authors>Thaunat O</pubmed_authors><pubmed_authors>Cuozzo S</pubmed_authors><pubmed_authors>Barbosa S</pubmed_authors><pubmed_authors>Sicard A</pubmed_authors><pubmed_authors>Ben Hassen N</pubmed_authors><pubmed_authors>Cremoni M</pubmed_authors><pubmed_authors>Durand M</pubmed_authors><pubmed_authors>Martinuzzi E</pubmed_authors><pubmed_authors>Le Quintrec M</pubmed_authors></additional><is_claimable>false</is_claimable><name>Low T Cell Responsiveness in the Early Phase of COVID-19 Associates with Progression to Severe Pneumonia in Kidney Transplant Recipients.</name><description>Kidney transplant (KT) recipients are at increased risk of developing severe forms of COVID-19. Little is known about the immunological mechanisms underlying disease severity in these patients receiving T-cell targeting immunosuppressive drugs. We investigated the relationship between T cell responsiveness at the beginning of the infection and the risk of subsequent progression to respiratory failure. We performed a multicentric prospective study in KT recipients with a positive RT-PCR COVID-19 test and only mild symptoms at inclusion. Blood samples were collected at baseline in a cell culture system containing T cell stimuli. We assessed T cell responsiveness by computing the ratio between the levels of Th1, Th2, Th17 and Treg cytokines produced after polyclonal stimulation and the number</description><dates><release>2022-01-01T00:00:00Z</release><publication>2022 Mar</publication><modification>2025-04-04T08:24:39.269Z</modification><creation>2024-12-04T00:55:15.981Z</creation></dates><accession>S-EPMC8949290</accession><cross_references><pubmed>35336949</pubmed><doi>10.3390/v14030542</doi></cross_references></HashMap>